Rush Univ. Med. Ctr. ACTG CRS (2702) — Chicago, Illinois

Rush Univ. Med. Ctr. ACTG CRS (2702) is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Rush Univ. Med. Ctr. ACTG CRS (2702) has participated in 13 clinical trials.

Therapeutic areas: HIV-1 Infection, HIV Infections, Hepatitis.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Univ. Med. Ctr. ACTG CRS (2702)?

Rush Univ. Med. Ctr. ACTG CRS (2702) has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Univ. Med. Ctr. ACTG CRS (2702) conducted?

Rush Univ. Med. Ctr. ACTG CRS (2702) has 13 clinical trials on record. Their work covers HIV-1 Infection, HIV Infections, Hepatitis.

Is Rush Univ. Med. Ctr. ACTG CRS (2702) accredited by Crixeo Health?

Rush Univ. Med. Ctr. ACTG CRS (2702) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush Univ. Med. Ctr. ACTG CRS (2702)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.